Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.

Atherosclerosis·2022
Same author

Inter-arm systolic blood pressure difference: non-persistence and association with incident cardiovascular disease in the Multi-ethnic Study of Atherosclerosis.

Journal of human hypertension·2022
Same author

Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.

International journal of cardiology·2021
Same author

Associations of endogenous sex hormone levels with the prevalence and progression of valvular and thoracic aortic calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).

Atherosclerosis·2021
Same author

Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.

Journal of the American Heart Association·2021
Same author

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus.

The Annals of pharmacotherapy·2020

Related Experiment Video

Updated: May 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K

Bleeding risk prediction models in atrial fibrillation.

Isac C Thomas1, Matthew J Sorrentino

  • 1Department of Medicine, Section of Cardiology, University of Chicago, 5841 S. Maryland Ave, MC 6080, Chicago, IL, 60637, USA.

Current Cardiology Reports
|November 23, 2013
PubMed
Summary

Novel oral anticoagulants (OACs) are effective for stroke prevention in atrial fibrillation (AF) patients. This review discusses bleeding risk models to aid clinicians in managing OAC therapy in elderly AF patients.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.9K

Related Experiment Videos

Last Updated: May 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.9K

Area of Science:

  • Cardiology
  • Pharmacology
  • Geriatrics

Background:

  • Non-vitamin K antagonist oral anticoagulants (OACs) offer effective stroke prevention in atrial fibrillation (AF).
  • The rising prevalence of AF in the elderly population presents challenges for OAC therapy initiation.
  • Balancing the benefits of OACs against bleeding risks is crucial in elderly patients.

Purpose of the Study:

  • To review and discuss eight bleeding risk prediction models for OAC therapy in AF patients.
  • To provide clinicians with an overview of tools for assessing bleeding risk.
  • To aid in the clinical decision-making process for long-term OAC treatment in the elderly.

Main Methods:

  • Literature review of bleeding risk prediction models.
  • Discussion of the features of models including HEMORR2HAGES, HAS-BLED, and ATRIA.
  • Analysis of approaches to bleeding risk assessment in clinical practice.

Main Results:

  • Several bleeding risk prediction models exist to identify high-risk patients.
  • Models like HEMORR2HAGES, HAS-BLED, and ATRIA offer specific criteria for risk stratification.
  • These models aim to guide clinicians in optimizing OAC therapy decisions.

Conclusions:

  • Bleeding risk assessment is essential for safe and effective OAC use in AF.
  • Clinicians can utilize various prediction models to personalize OAC treatment strategies.
  • Careful consideration of bleeding risk is paramount, especially in the growing elderly AF population.